期刊文献+
共找到442篇文章
< 1 2 23 >
每页显示 20 50 100
Cantharidin and Its Analogues:Anticancer and Ser/Thr Protein Phosphatase Inhibitory Activities 被引量:5
1
作者 史清华 王玉玲 +1 位作者 宋宏锐 程卯生 《Journal of Chinese Pharmaceutical Sciences》 CAS 2005年第4期250-256,共7页
This paper mainly describes the anticancer activities and Ser/Thr protein phosphatase inhibitory activities of cantharidin and its analogues.
关键词 cantharidin analogues anticancer activity Ser/Thr protein phosphatase inhibitory activity
暂未订购
1,2-Cyclic Monoacyl-rac-Glycerothio-phosphates of Cantharidin Analogues 被引量:1
2
作者 Zheng Hong ZHOU Ru Yu CHEN(Institute of Elemento-Oganic Chemistry, Nankai University, Tianjin 300071) 《Chinese Chemical Letters》 SCIE CAS CSCD 1999年第2期113-114,共2页
A series of 1,2-cyclic monoacyl-rac-glycerothiophosphates of cantharidin and its analogues were synthesized in a one-pot procedure in overall yields of 44 similar to 55.5% by means of hexaethylphosphorus triamide as p... A series of 1,2-cyclic monoacyl-rac-glycerothiophosphates of cantharidin and its analogues were synthesized in a one-pot procedure in overall yields of 44 similar to 55.5% by means of hexaethylphosphorus triamide as phosphorylating reagent. 展开更多
关键词 SYNTHESIS cantharidin and its analogues cyclic glycerothiophosphate
在线阅读 下载PDF
Inhibitory Effect of Cantharidin on Proliferation of A549 Cells 被引量:1
3
作者 王晓华 尹元琴 +3 位作者 隋承光 孟凡东 马萍 姜又红 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 2007年第4期283-286,共4页
Objective: To study the inhibition of Cantharidin against the proliferation of human lung cancer A549 cells and its mechanism. Methods: MTT assay was employed to determine the inhibition of Cantharidin against proli... Objective: To study the inhibition of Cantharidin against the proliferation of human lung cancer A549 cells and its mechanism. Methods: MTT assay was employed to determine the inhibition of Cantharidin against proliferation of A549 cells and flow Cytometry was applied to analyze A549 cell cycle and the effect of Cantharidin on cell cycle. Results: Cantharidin showed inhibition against the proliferation of A549 cells, and the inhibition was mediated by blocking A549 cell cycle at G2/M phase significantly. Conclusion: Cantharidin exhibits inhibition against the proliferation of human lung cancer A549 cells. 展开更多
关键词 cantharidin(CTD) INHIBITION Human lung cancer cells A549
暂未订购
Multiorgan dysfunction syndrome due to high-dose cantharidin poisoning:A case report
4
作者 Wan-Ling Xu Wen-Jing Tang +4 位作者 Wei-Ying Yang Li-Chao Sun Ze-Qun Zhang Wei Li Xiu-Xian Zang 《World Journal of Clinical Cases》 SCIE 2024年第12期2074-2078,共5页
BACKGROUND This report delves into the diagnostic and therapeutic journey undertaken by a patient with high-dose cantharidin poisoning and multiorgan dysfunction syndrome(MODS).Particular emphasis is placed on the com... BACKGROUND This report delves into the diagnostic and therapeutic journey undertaken by a patient with high-dose cantharidin poisoning and multiorgan dysfunction syndrome(MODS).Particular emphasis is placed on the comprehensive elucidation of the clinical manifestations of high-dose cantharidin poisoning,the intricate path to diagnosis,and the exploration of potential underlying mechanisms.CASE SUMMARY A patient taking 10 g of cantharidin powder orally subsequently developed MODS.The patient was treated with supportive care,fluid hydration and antibiotics,and hemoperfusion and hemofiltration therapy for 24 h and successfully recovered 8 d after hospital admission.Cantharidin poisoning can cause lifethreatening MODS and is rare clinically.This case underscores the challenge in diagnosis and highlights the need for early clinical differentiation to facilitate accurate assessment and prompt intervention.CONCLUSION This article has reported and analyzed the clinical data,diagnosis,treatment,and prognosis of a case of high-dose cantharidin poisoning resulting in MODS and reviewed the relevant literature to improve the clinical understanding of this rare condition. 展开更多
关键词 cantharidin POISONING Multiorgan dysfunction syndrome Clinical treatment and management Case report
暂未订购
Cantharidin suppresses HCT116 colorectal carcinoma cell proliferation and migration by changing the cytoskeleton structure
5
作者 Xin Zhang Tongtong Sui +5 位作者 Qixiang Ma Haozhen Shao Xiaowei Hu Honghao Sheng Zhitao Ma Guangbin Luo 《Journal of Traditional Chinese Medical Sciences》 2018年第3期302-309,共8页
Background:Cantharidin (CTD),a natural toxin produced from Chinese blister beetles,has extensive anti-tumor activity.The present study investigated the effect of CTD on a human colon cancer cell line to elucidate pote... Background:Cantharidin (CTD),a natural toxin produced from Chinese blister beetles,has extensive anti-tumor activity.The present study investigated the effect of CTD on a human colon cancer cell line to elucidate potential new insights regarding the mechanism(s) through which CTD exerts its anti-tumor effects.Materials and methods:The inhibitory effect of CTD on human colon cancer HCT116 cells was evaluated using the IncuCyte ZOOMTM analyzer.Apoptotic cells were detected by Annexin V-FITC/PI assay and cell cycle was evaluated with flow cytometry following propidium iodide staining.Alterations in F-actin microfilaments were analyzed by FITC-phalloidin staining and morphological changes were evaluated with a laser scanning confocal microscope.Cell migration assay was carried out to investigate the effects of CTD on migration of HCT116 cells in vitro.Results:CTD exhibited a significant growth inhibitory effect on HCT116 cells accompanied by an increase in G2/M phase cells,without a significant effect on apoptosis.CTD-treated cells also exhibited a dramatic collapse in their microfilament network and a significant reduction in cell adhesion.Conclusion:CTD inhibits growth by increasing G2/M phase cells and decreasing S phase cells,revealing that CTD exerts a significant growth inhibitory effect primarily through an inhibition of cell cycle progression (a cytostatic effect).Moreover,a negative effect on cell migration may also constitute a contributing factor to its anti-tumor potential.These findings suggest the potential use for developing CTD as a novel anti-cancer therapy that targets metastasis Giving full play to CTD may inhibit tumor transfer. 展开更多
关键词 cantharidin ACTIN CYTOSKELETON Cell adhesion Proliferation MIGRATION
暂未订购
Analysis of the metabolic mechanism in Cantharidin-induced hepatotoxicity in LO2 cells using lipidomics analysis
6
作者 Jian-Yong Zhang Fang Liu +5 位作者 Tian-Mu He Qi-Yi Wang Yan Zhang Xiao-Yan Yuan Xiao-Fei Li Can-Can Duan 《Asian Toxicology Research》 2021年第2期14-24,共11页
Background:Cantharidin is a major active compound from Banmao(Mylabris).Cantharidin has obvious anticancer activity.However,its clinical application is limited due to serious hepatotoxicity.Methods:To evaluate the tox... Background:Cantharidin is a major active compound from Banmao(Mylabris).Cantharidin has obvious anticancer activity.However,its clinical application is limited due to serious hepatotoxicity.Methods:To evaluate the toxicity of human liver LO2 cells exposed to cantharidin by lipidomics.After exposing LO2 cells to different doses of cantharidin,the metabolites in LO2 cells were analyzed by nontargeted lipidomics based on liquid chromatography-mass spectrometry.Partial least-squares discriminant analysis and orthogonal partial least-squares discriminant analysis were used to screen differentially expressed metabolites,and then the main metabolic pathways were analyzed.Results:Pattern recognition analysis showed that the lipid metabolite profiles were changed significantly after cantharidin treatment,and 39 differential lipid metabolites were found.Additional analysis showed that these metabolites could mainly involve the metabolic pathways of triglyceride and acylcarnitine for cantharidin toxicity to LO2 cells.Conclusion:Cantharidin has obvious toxic effects on LO2 cells from the perspective of lipid metabolism.Moreover,the LO2 cytotoxicity induced by cantharidin is mainly related to the disorder of triglyceride and acylcarnitine metabolism.It can provide a scientific basis for cantharidin-induced hepatotoxicity. 展开更多
关键词 Hepatoxicity cantharidin LC-MS LIPIDOMICS
暂未订购
Protective effect of glycyrrhetinic acid against cantharidin-induced hepatotoxicity through reducing oxidative stress in mice
7
作者 Li-Juan Xiong Xiao-Hong Zhang +4 位作者 Jia-Lu Zou Xuan Chen Wen-Zhong Feng Cong-Yun Meng Jian-Yong Zhang 《Toxicology Advances》 2024年第1期3-9,共7页
Background:Cantharidin(CTD)is a commonly used natural product with anticancer properties;however,it has significant adverse effects,particularly hepatotoxicity.Glycyrrhetinic acid(GA),the active component of licorice,... Background:Cantharidin(CTD)is a commonly used natural product with anticancer properties;however,it has significant adverse effects,particularly hepatotoxicity.Glycyrrhetinic acid(GA),the active component of licorice,shows potential hepatoprotective effects.The protective effects and mechanism of GA against CTD-induced hepatotoxicity are still unclear.Objective:This study aims to elucidate the effect and mechanism of GA on CTD-induced hepatotoxicity in mice experiments.Methods:Construction of CTD-induced hepatotoxicity models and oral gavage GA intervention for 14 d.The liver index,ALT,AST and LDH levels in the serum of the mice were examined;HE staining was performed to observe pathological changes in the liver.The MDA level and SOD activities in liver tissue were tested.Western blot was conducted to determine Keap1/Nrf2 signaling pathway-related protein expression.Results:The results showed that GA significantly reduced the levels of ALT,AST,and LDH in the serum,which were increased by CTD.Additionally,it also exerted a substantial inhibitory effect on the reduction of SOD activity and the elevation of malondialdehyde content in liver tissue.Notably,the phenomena of nuclear swelling,necrosis,and inflammatory infiltration of liver tissue were significantly attenuated following oral administration of GA in mice.Subsequent research has demonstrated that GA effectively suppressed the CTD-triggered upregulation of Keap1 while increasing the CTD-induced downregulation of Nrf2,HO-1,and NQO1.Conclusion:These findings suggested that GA may protect against CTD-induced hepatotoxicity in mice by exerting antioxidative stress through the Keap1/Nrf2 signaling pathway. 展开更多
关键词 glycyrrhetinic acid cantharidin HEPATOTOXICITY oxidative stress Nrf2/Keap1
暂未订购
Disorder of phospholipid metabolism in the renal cortex and medulla contributes to acute tubular necrosis in mice after cantharidin exposure using integrative lipidomics and spatial metabolomics
8
作者 Tianmu He Kexin Lin +5 位作者 Lijuan Xiong Wen Zhang Huan Zhang Cancan Duan Xiaofei Li Jianyong Zhang 《Journal of Pharmaceutical Analysis》 2025年第7期1526-1541,共16页
Cantharidin (CTD), a natural compound used to treat multiple tumors in the clinic setting, has been limited due to acute kidney injury (AKI). However, the major cause of AKI and its underlying mechanism remain to be e... Cantharidin (CTD), a natural compound used to treat multiple tumors in the clinic setting, has been limited due to acute kidney injury (AKI). However, the major cause of AKI and its underlying mechanism remain to be elucidated. Serum creatinine (SCr) and blood urea nitrogen (BUN) were detected through pathological evaluation after CTD (1.5 mg/kg) oral gavage in mice in 3 days. Kidney lipidomics based on ultra-high performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) was used to investigate lipids disorder after CTD exposure in mice. Then, spatial metabolomics based on matrix-assisted laser desorption/ionization-mass spectrometry imaging (MALDI-MSI) was used to detect the kidney spatial distribution of lipids. Integrative analysis was performed to reveal the spatial lipid disorder mechanism and verify key lipids in vitro. The results showed that the levels of SCr and BUN were increased, and tubular necrosis was observed in mouse kidneys, resulting in acute tubular necrosis (ATN) in CTD-induced AKI. Then, lipidomics results revealed that after CTD exposure, 232 differential lipid metabolites and 11 pathways including glycerophospholipid (GP) and sphingolipid (SL) metabolism were disrupted. Spatial metabolomics revealed that 55 spatial differential lipid metabolites and nine metabolic pathways were disturbed. Subsequently, integrative analysis found that GP metabolism was stimulated in the renal cortex and medulla, whereas SL metabolism was inhibited in the renal cortex. Up-regulated lysophosphatidylcholine (LysoPC) (18:2(9Z,12Z)), LysoPC (16:0/0:0), glycerophosphocholine, and down-regulated sphingomyelin (SM) (d18:0/16:0), SM (d18:1/24:0), and SM (d42:1) were key differential lipids. Among them, LysoPC (16:0/0:0) was increased in the CTD group at 1.1196 μg/mL, which aggravated CTD-induced ATN in human kidney-2 (HK-2) cells. LysoPC acyltransferase was inhibited and choline phosphotransferase 1 (CEPT1) was activated after CTD intervention in mice and in HK-2 cells. CTD induces ATN, resulting in AKI, by activating GP metabolism and inhibiting SL metabolism in the renal cortex and medulla, LysoPC (16:0/0:0), LysoPC acyltransferase, and CEPT1 may be the therapeutic targets. 展开更多
关键词 Acute kidney injury Acute tubular necrosis cantharidin Glycerophospholipid metabolism Spatial metabolomics Sphingolipid metabolism
暂未订购
Physicochemical Properties and Gastric Mucosa Irritation of Cantharidin-hydroxypropyl-β-cyclodextrin Inclusion Complex 被引量:5
9
作者 Lin-na AN Yun-jie DANG +1 位作者 Chun-hui HU Chun-yan ZHU 《Chinese Herbal Medicines》 CAS 2012年第3期224-229,共6页
Objective To increase the solubility and relieve the mucous irritation of cantharidin (CA) by preparing cantharidin-hydroxypropyl-β-cyclodextrin (CA/HP-β-CD) inclusion complex. Methods The inclusion complex was prep... Objective To increase the solubility and relieve the mucous irritation of cantharidin (CA) by preparing cantharidin-hydroxypropyl-β-cyclodextrin (CA/HP-β-CD) inclusion complex. Methods The inclusion complex was prepared by co-evaporation method and characterized by differential scanning calorimetry (DSC), X-ray diffractometry (XRD), and nuclear magnetic resonance (NMR). Results The disappearance of CA as well as the shift of exothermic peaks shown in DSC results indicated the complexation phenomenon. XRD results showed that the crystalline CA pattern had disappeared, and in NMR results, H-5 shifted from δ 3.731 to 3.695 after complexation and H-2 shifted from δ 3.626 to 3.598, which suggested that part of the drug had entered the HP-β-CD cavity to form an inclusion complex. The solubility increased 10.3 times after complexation and the mucous irritation of CA was relieved remarkably. Conclusion Through complexation with HP-β-CD, the solubility and dissolution rate of CA are improved significantly, and the irritation of musous is relieved. 展开更多
关键词 cantharidin DISSOLUTION HYDROXYPROPYL-Β-CYCLODEXTRIN mucous irritation SOLUBILITY
原文传递
Hydroxycamptothecine and Cantharidin Combined with Cisplatinand Lipiodol Through Transcatheter Arterial Embolizalionin Hepatocellular Carcinoma
10
作者 于志坚 孟宪镛 +1 位作者 徐克成 葛政举 《Chinese Journal of Integrative Medicine》 SCIE CAS 1995年第3期175-178,共4页
Transcatheter arterial embolization with hydroxycamptothecine, cantharidin and cisplatin,thoroughly mixed with large doses of interferon and interleukin-2, was performed in 48 cases with unre-sectable intermediate or ... Transcatheter arterial embolization with hydroxycamptothecine, cantharidin and cisplatin,thoroughly mixed with large doses of interferon and interleukin-2, was performed in 48 cases with unre-sectable intermediate or advanced hepatocellular carcinoma. The results demonstrate a partial remissionrate of 54. 2%, significantly higher than that in embolization with chemotherapeutic agents alone (cis-platin, adriamycin and mitomycin, 32. 1%, P<O. 01) . Morever, the adverse reactions of hydroxycamp-tothecine and cantharidin, when applied systemically, including hematuria or urodynia were successfullyeliminated. 展开更多
关键词 hydroxycamptothecine. cantharidin hepatocellular carcinoma transcatheter arterialembolization
原文传递
The first chromosome-level genome assembly and transcriptome sequencing provide insights into cantharidin production of the blister beetles
11
作者 Chuang ZHOU Xiaofeng ZHENG +3 位作者 Lei WANG Bisong YUE Chao DU Xu LIU 《Integrative Zoology》 CSCD 2024年第5期929-940,共12页
Blister beetles(Coleoptera:Meloidae)produce a natural defensive toxin cantharidin(CTD),which has been used for various cancer treatments and other diseases.Currently,the lack of chromosome-level reference genomes in M... Blister beetles(Coleoptera:Meloidae)produce a natural defensive toxin cantharidin(CTD),which has been used for various cancer treatments and other diseases.Currently,the lack of chromosome-level reference genomes in Meloidae limits further understanding of the mechanism of CTD biosynthesis and environmental adaptation.In this study,the chromosome-level genome assembly of Mylabris phalerata was generated based on PacBio and Hi-C sequencing.This reference genome was about 136.68 Mb in size with contig N50 of 9.17 Mb and composed of 12 chromosomes.In comparison to six other Coleoptera insects,M.phalerata exhibited multiple expanded gene families enriched in juvenile hormone(JH)biosynthetic process pathway,farnesol dehydrogenase activity,and cytochrome P450,which may be related to CTD biosynthesis.Consistently,the transcriptomic analysis suggested the“terpenoid backbone biosynthesis”pathway and“the juvenile hormone”as putative core pathways of CTD biosynthesis and presented eight up-regulated differential expression genes in male adults as candidate genes.It is possible that the restricted feeding niche and lifestyle of M.phalerata were the cause of the gene family’s contraction of odorant binding proteins.The ABC transporters(ABCs)related to exporting bound toxins out of the cell and the resistance to the self-secreted toxins(e.g.CTD)were also contracted,possibly due to other self-protection strategies in M.phalerata.A foundation of understanding CTD biosynthesis and environmental adaptation of blister beetles will be established by our reference genome and discoveries. 展开更多
关键词 blister beetle cantharidin biosynthesis chromosome-level genome cytochrome P450 differentially expressed gene Mylabris phalerata sexual dimorphism
原文传递
CO_(2)激光术联合复方斑蝥胶囊治疗早期声门型喉癌临床价值研究 被引量:1
12
作者 王立娟 刘志华 王东亚 《陕西医学杂志》 2025年第5期674-677,682,共5页
目的:探究CO_(2)激光术联合复方斑蝥胶囊治疗早期声门型喉癌的临床价值。方法:选取80例早期声门型喉癌患者,随机分为手术组(40例)和联合组(40例)。手术组给予CO_(2)激光术联合含0.9%氯化钠溶液胶囊治疗,联合组给予CO_(2)激光术联合复方... 目的:探究CO_(2)激光术联合复方斑蝥胶囊治疗早期声门型喉癌的临床价值。方法:选取80例早期声门型喉癌患者,随机分为手术组(40例)和联合组(40例)。手术组给予CO_(2)激光术联合含0.9%氯化钠溶液胶囊治疗,联合组给予CO_(2)激光术联合复方斑蝥胶囊治疗。比较两组治疗前及治疗后1年嗓音功能、免疫功能、吞咽功能及生活质量。两组治疗后随访1年,记录患者复发情况。结果:治疗后1年,两组患者谐噪比高于治疗前,基频微扰、振幅微扰低于治疗前,且联合组谐噪比高于手术组,基频微扰、振幅微扰低于手术组(均P<0.05)。治疗后1年,手术组CD3^(+)、CD4^(+)、CD4^(+)/CD8^(+)水平低于治疗前,联合组CD3^(+)、CD4^(+)、CD4^(+)/CD8^(+)水平高于治疗前,且联合组高于手术组(均P<0.05)。治疗后1年,两组吞咽功能评估量表(GUSS)评分和功能、总体生命质量评分高于治疗前,症状评分低于治疗前,且联合组GUSS评分和功能、总体生命质量评分高于手术组,症状评分低于手术组(均P<0.05)。两组治疗后1年复发率比较差异无统计学意义(P>0.05)。结论:CO_(2)激光术联合复方斑蝥胶囊治疗早期声门型喉癌能够促进嗓音功能恢复,改善免疫及吞咽功能,提高患者生活质量。 展开更多
关键词 早期声门型喉癌 CO_(2)激光术 复方斑蝥胶囊 嗓音功能 免疫功能 吞咽功能 生活质量
暂未订购
GCDH在抗癌药物斑蝥素生物合成机制中的功能探索
13
作者 廖玉凤 王宇 《医学研究与教育》 2025年第1期14-25,共12页
目的获取眼斑芫菁戊二酰辅酶A脱氢酶(Glutaryl-CoA dehydrogenase,GCDH)基因全长cDNA序列,并探索GCDH在抗癌药物斑蝥素生物合成机制中的潜在功能。方法从早期构建的眼斑芫菁cDNA文库中筛选出GCDH片段,利用RACE技术扩增该基因全长cDNA序... 目的获取眼斑芫菁戊二酰辅酶A脱氢酶(Glutaryl-CoA dehydrogenase,GCDH)基因全长cDNA序列,并探索GCDH在抗癌药物斑蝥素生物合成机制中的潜在功能。方法从早期构建的眼斑芫菁cDNA文库中筛选出GCDH片段,利用RACE技术扩增该基因全长cDNA序列,通过RT-qPCR测定眼斑芫菁成虫不同时期(5、10、15、22、25、30 d)GCDH的表达量,并利用在线NCBI数据库进行Blast比对,利用在线资源对GCDH进行结构生物学预测。结果本研究成功获取了眼斑芫菁GCDH基因的全长cDNA序列1338 bp,登录号为MK370842。GCDH的开放阅读框为1260 bp,共编码419个氨基酸残基,系统进化分析结果显示,该基因编码的蛋白与赤拟谷盗(XP_971662)在系统进化关系上最近。RT-qPCR结果显示,该基因在眼斑芫菁雌、雄成虫的表达具有差异性,且在雄虫斑蝥素大量合成的前期(15 d)大量表达。结论眼斑芫菁中的GCDH基因在斑蝥素生物合成过程中可能扮演着重要角色。特别是在雄虫中,GCDH在斑蝥素大量合成的前期大量表达,这进一步提示,氨基酸代谢可能与斑蝥素的合成具有密切的相关性。这些发现为进一步研究斑蝥素生物合成机制及人工养殖获取高含量斑蝥素的斑蝥提供可借鉴的思路和理论基础。 展开更多
关键词 戊二酰辅酶A脱氢酶 眼斑芫菁 斑蝥素生物合成机制
在线阅读 下载PDF
叶酸修饰的斑蝥素/黄芩苷脂质体在正常大鼠与荷瘤大鼠体内的药动学及组织分布差异研究
14
作者 高昱 杨磊 +5 位作者 金凯 肖望重 王璐 戴冰 鹿爱娟 黄莉 《中国药学杂志》 北大核心 2025年第1期39-46,共8页
目的评价叶酸修饰的斑蝥素/黄芩苷脂质体(DSPE-PEG2k-folate-cantharidin&baicalin@lipsomes,FA-Can&Bai@Lips)在正常大鼠与荷瘤大鼠体内的药动学及组织分布差异。方法以HepG2细胞悬液接种于大鼠右侧腋下诱导荷瘤大鼠模型,尾静... 目的评价叶酸修饰的斑蝥素/黄芩苷脂质体(DSPE-PEG2k-folate-cantharidin&baicalin@lipsomes,FA-Can&Bai@Lips)在正常大鼠与荷瘤大鼠体内的药动学及组织分布差异。方法以HepG2细胞悬液接种于大鼠右侧腋下诱导荷瘤大鼠模型,尾静脉注射FA-Can&Bai@Lips后采集不同给药时间点血浆与组织(心、肝、脾、肺、肾),采用超高效液相色谱-串联质谱联用技术(UPLC-MS/MS)测定血浆及组织中斑蝥素和黄芩苷浓度,应用Phoenix WinNonlin软件计算药动学参数,并分析比较FA-Can&Bai@Lips在正常机体状态与荷瘤状态下的药动学和组织分布差异。结果建立的同时测定斑蝥素与黄芩苷的UPLC-MS/MS方法线性关系良好,专属性、准确度与精密度、提取回收率与基质效应及稳定性等均符合生物样本检测要求。药动学参数表明,与正常组大鼠相比,荷瘤大鼠体内斑蝥素与黄芩苷的药时曲线下面积(area under the curve,AUC0-t、AUC0-∞)、平均驻留时间(mean residence time,MRT0-t、MRT0-∞)均显著升高(P<0.05),分别增加了55.68%、72.50%、43.10%、45.95%和15.10%、42.54%、9.09%、10.53%;斑蝥素在荷瘤大鼠体内半衰期(half-life,t1/2)缩短,但无显著性差异,而黄芩苷的t1/2显著延长(P<0.05),两者的表观分布容积(apparent volume of distribution,Vd)与清除率(clearance rate,CL)均明显降低。组织分布结果显示,斑蝥素与黄芩苷在荷瘤大鼠肝脏中浓度明显高于正常大鼠,其余组织药物浓度均显著低于正常大鼠。结论UPLC-MS/MS法分析速度快、简单、特异、灵敏,可用于大鼠血浆及组织中斑蝥素与黄芩苷的测定,且证实荷瘤状态会对FA-Can&Bai@Lips的体内药动学及组织分布产生明显影响。 展开更多
关键词 超高效液相色谱-串联质谱法 斑蝥素 黄芩苷 脂质体 荷瘤大鼠 药动学 组织分布
原文传递
共载斑蝥素和星形孢菌素脂质体的制备及协同抗肝癌作用研究
15
作者 贺锦程 韦爱秋 +1 位作者 钟子怡 张晓青 《中国药学杂志》 北大核心 2025年第11期1179-1186,共8页
目的探索斑蝥素(CTD)与星形孢菌素(STS)最佳协同比例,构建CTD-STS共载脂质体纳米递送体系(CTD-STS/NL)并表征其药剂学性质,研究其体外抗肝癌作用及机制。方法通过Chou-Talalay法探索出最佳协同比例,用薄膜分散法制备CTD-STS/NL,通过激... 目的探索斑蝥素(CTD)与星形孢菌素(STS)最佳协同比例,构建CTD-STS共载脂质体纳米递送体系(CTD-STS/NL)并表征其药剂学性质,研究其体外抗肝癌作用及机制。方法通过Chou-Talalay法探索出最佳协同比例,用薄膜分散法制备CTD-STS/NL,通过激光粒度分析仪、透射电镜进行表征,通过稳定性、溶血性及毒性实验进行评价,采用葡聚糖凝胶微柱离心联合高效液相色谱(HPLC)法测定CTD和STS的包封率。通过CCK8法、流式细胞仪、蛋白质免疫印迹(Western Blot)实验分别检测其对H22肝癌细胞抑制增殖及凋亡作用,并探究其作用机制。结果CTD与STS的最佳质量浓度比为588∶1。CTD-STS/NL分散均匀,形态圆整,带有淡蓝色乳光,平均粒径、多分散系数(PDI)、Zeta电位分别为(82.44±1.13)nm、(0.198±0.15)、(-1.12±0.15)mV。在血清中孵育48 h、4℃条件下保存40 d稳定性良好,溶血率小于2%。CTD、STS的平均包封率分别为(89.95±1.49)%、(95.36±0.81)%。CTD-STS/NL对H22肝癌细胞的半抑制浓度(IC50)(0.25±0.01)μg·mL^(-1)比CTD的降低60%,凋亡率(24.62±1.26)%明显高于CTD、STS独立用药组。机制研究结果表明可明显下调血管内皮生长因子(VEGF)、缺氧诱导因子-α(HIF-1α)、哺乳动物雷帕霉素靶蛋白(mTOR)蛋白的表达。结论CTD-STS/NL药剂学性质较好且稳定,可用于静脉注射给药,CTD-STS协同显著增强抗肝癌作用、促进H22细胞凋亡。可同时下调mTOR/HIF-1α/VEGF信号通路关键蛋白mTOR、HIF-1α、VEGF。为后续研发协同增效减毒、不易耐药、副作用小的中药复合抗肝癌靶向制剂开辟思路、奠定基础。 展开更多
关键词 斑蝥素 星形孢菌素 肝癌 脂质体
原文传递
叶酸修饰的共载斑蝥素和星形孢菌素脂质体的制备及其性质评价
16
作者 钟子怡 韦爱秋 +2 位作者 贺锦程 陈伶利 张晓青 《中国新药杂志》 北大核心 2025年第9期978-985,共8页
目的:制备叶酸修饰的共载斑蝥素和星形孢菌素的脂质体纳米递送体系(folic acid-modified liposomes nanodelivery system co-loaded with cantharidin and staurosporine,FA/CTD-STS/NL),并对其性质进行评价。方法:采用薄膜分散法制备FA... 目的:制备叶酸修饰的共载斑蝥素和星形孢菌素的脂质体纳米递送体系(folic acid-modified liposomes nanodelivery system co-loaded with cantharidin and staurosporine,FA/CTD-STS/NL),并对其性质进行评价。方法:采用薄膜分散法制备FA/CTD-STS/NL,用凝胶柱-HPLC法测定脂质体的包封率。用透射电镜(transmission electron microscopy,TEM)观察脂质体的形态,激光粒度分析仪测定脂质体的粒径及其分布、Zeta电势,并考察其血清稳定性、长期稳定性和血液相容性。通过CCK-8法检测其细胞毒性。结果:FA/CTD-STS/NL外观呈类球形,分散均匀。平均粒径、多分散性指数、Zeta电势分别为(114.3±0.9)nm,(0.212±0.018)和-(1.19±0.13)mV,平均包封率分别为(89.62±0.67)%和(96.01±1.02)%。其血清稳定性和长期稳定性良好,溶血率均<5%,说明具有良好的血液相容性。FA/CTD-STS/NL对小鼠正常肝细胞(AML-12细胞)具有良好的细胞相容性。结论:本研究制备的FA/CTD-STS/NL具有良好的稳定性和生物安全性,包封率高,粒径符合抗癌纳米递送载体的要求,有利于药物在肿瘤组织的富集。本研究为后续FA/CTD-STS/NL体内外靶向性、抗肝癌作用及机制研究奠定实验基础。 展开更多
关键词 叶酸 斑蝥素 星形孢菌素 脂质体 纳米载药递送系统
原文传递
斑蝥酸钠维生素B_(6)注射液对人肝癌细胞的作用及其机制 被引量:1
17
作者 思兰兰 许文 +6 位作者 李乐 纪冬 陈雪媛 戴久增 姚增涛 陈威巍 刘妍 《解放军医学杂志》 北大核心 2025年第6期747-755,共9页
目的分析斑蝥酸钠维生素B_(6)注射液(SCV)对4种人肝癌细胞(SMMC-7721、Bel-7402、Huh7、HepG2)的作用及其机制。方法设置未用药对照组(0μmol/L)和0.5、1、2、4、8、16、32μmol/L SCV组,处理正常肝细胞系L02,采用CCK-8法检测SCV对L02... 目的分析斑蝥酸钠维生素B_(6)注射液(SCV)对4种人肝癌细胞(SMMC-7721、Bel-7402、Huh7、HepG2)的作用及其机制。方法设置未用药对照组(0μmol/L)和0.5、1、2、4、8、16、32μmol/L SCV组,处理正常肝细胞系L02,采用CCK-8法检测SCV对L02细胞的毒性作用。培养人肝癌细胞系SMMC-7721、Bel-7402、Huh7、HepG2,设置未用药对照组(0μmol/L)和2、4、8μmol/L SCV组。采用CCK-8法、平板克隆实验、Transwell实验和细胞划痕实验、流式细胞实验分别检测SCV对4种肝癌细胞的生长增殖能力、细胞克隆形成能力、细胞侵袭和迁移能力、细胞周期和细胞凋亡的影响。采用Western blotting检测凋亡相关的核因子κB亚基p65(p65)、B细胞淋巴瘤2家族蛋白质(Bcl-2)和胱天蛋白酶-3(Caspase-3)的表达情况,并初步探索其作用机制。结果CCK-8法检测结果显示,与未用药对照组(0μmol/L)比较,0.5、1、2、4、8μmol/L SCV对L02细胞无明显的毒性作用,选择2、4、8μmol/L SCV进行后续实验。与未用药对照组(0μmol/L)比较,不同浓度(2、4、8μmol/L)的SCV均可明显抑制4种肝癌细胞的增殖能力(P<0.001)。平板克隆实验结果显示,与未用药对照组(0μmol/L)比较,不同浓度(2、4、8μmol/L)的SCV均可明显降低4种肝癌细胞的克隆形成能力(P<0.05或P<0.01或P<0.001)。此外,Transwell和细胞划痕实验结果显示,与未用药对照组(0μmol/L)比较,不同浓度(2、4、8μmol/L)的SCV可明显抑制肝癌细胞的侵袭和迁移(P<0.05或P<0.01或P<0.001)。在上述结果中,SCV的抑制作用均呈浓度依赖性。流式细胞检测结果显示,SCV可将细胞阻滞于G2/M期(P<0.05或P<0.01或P<0.001),并可明显促进细胞凋亡(P<0.05或P<0.01或P<0.001)。Western blotting检测结果显示,SCV可明显下调p65(P<0.05或P<0.01)和Bcl-2的表达(P<0.05),上调Caspase-3的表达(P<0.05或P<0.01)。结论SCV可明显抑制多种人肝癌细胞的增殖、克隆形成、侵袭和迁移,并可阻滞细胞周期进程。SCV可能通过抑制p65、Bcl-2的表达,从而解除其对凋亡通路的抑制作用,进而激活Caspase-3促进凋亡的发生。 展开更多
关键词 斑蝥酸钠维生素B_(6)注射液 人肝癌细胞系 细胞增殖 细胞周期 细胞凋亡
暂未订购
复方斑蝥胶囊联合白蛋白结合型紫杉醇+卡铂化疗方案对晚期三阴性乳腺癌患者血清肿瘤标志物水平的影响
18
作者 张亚锋 冯誉慧 +2 位作者 刘平贤 李长生 袁小笋 《中医药临床杂志》 2025年第10期2102-2106,共5页
目的:探究复方斑蝥胶囊联合白蛋白结合型紫杉醇+卡铂化疗方案对晚期三阴性乳腺癌(TNBC)患者血清肿瘤标志物水平的影响。方法:选取南阳市中心医院2020年10月—2024年6月78例TNBC患者,采用随机数字表法分为对照组、观察组,各39例。对照组... 目的:探究复方斑蝥胶囊联合白蛋白结合型紫杉醇+卡铂化疗方案对晚期三阴性乳腺癌(TNBC)患者血清肿瘤标志物水平的影响。方法:选取南阳市中心医院2020年10月—2024年6月78例TNBC患者,采用随机数字表法分为对照组、观察组,各39例。对照组采用白蛋白结合型紫杉醇+卡铂化疗方案,观察组在对照组基础上采用复方斑蝥胶囊,21d为1个疗程,连续治疗3个疗程。比较2组临床疗效、不良反应、生活质量和治疗前、治疗3个疗程后肿瘤标志物[糖链抗原15-3(CA15-3)、糖链抗原125(CA125)、癌胚抗原(CEA)]、免疫功能(CD3+、CD4+、CD8+)水平。结果:观察组DCR(53.85%)高于(30.77%);观察组治疗3个疗程后CA15-3、CA125、CEA水平低于对照组;观察组治疗3个疗程后CD3+、CD4+、CD4+/CD8+水平高于对照组;观察组治疗3个疗程后KPS评分高于对照组,以上差异均有统计学意义。2组不良反应比较,无显著差异。结论:复方斑蝥胶囊联合白蛋白结合型紫杉醇+卡铂化疗方案治疗晚期TNBC疗效确切,具有抑制肿瘤标志物水平、改善免疫功能的作用。 展开更多
关键词 复方斑蝥胶囊 白蛋白结合型紫杉醇 卡铂 乳腺癌 肿瘤标志物
暂未订购
斑蝥酸钠抗肿瘤作用机制及其注射剂临床应用研究进展
19
作者 杨雅信 张方博 蔡晴晴 《药学研究》 2025年第7期718-724,共7页
斑蝥酸钠(disodium cantharidinate)为中药斑蝥的活性成分斑蝥素的衍生化合物。研究表明,斑蝥酸钠对肝癌、肺癌和乳腺癌等多种肿瘤细胞具有抑制作用,且毒性、刺激性较斑蝥素降低。作用机制可能与阻滞细胞周期、抑制增殖、促进凋亡和抑... 斑蝥酸钠(disodium cantharidinate)为中药斑蝥的活性成分斑蝥素的衍生化合物。研究表明,斑蝥酸钠对肝癌、肺癌和乳腺癌等多种肿瘤细胞具有抑制作用,且毒性、刺激性较斑蝥素降低。作用机制可能与阻滞细胞周期、抑制增殖、促进凋亡和抑制肿瘤血管生成等有关。此外,以斑蝥酸钠为活性成分的抗癌注射剂(如:斑蝥酸钠注射液、斑蝥酸钠维生素B 6注射液)在临床应用广泛,除抗肿瘤作用外,亦减轻化疗副作用。本文就斑蝥酸钠抗癌作用机制、临床应用及药物相互作用等方面进行总结,以期为斑蝥酸钠的进一步研究和临床再定位提供参考。 展开更多
关键词 斑蝥酸钠 注射剂 抗肿瘤 CYP450
暂未订购
斑蝥素对肺动脉平滑肌细胞增殖、自噬及PKC/ERK信号通路的作用机制研究
20
作者 张开亚 李夏 +1 位作者 杨琴 徐瑶瑶 《新中医》 2025年第9期229-234,共6页
目的:观察斑蝥素对肺动脉平滑肌细胞增殖、自噬及PKC/ERK信号通路的作用机制。方法:2只SPF级SD大鼠处死提取肺组织中平滑肌细胞(PASMCs),采用免疫组化法检测α-SMA表达。将PASMCs细胞分为对照组、低氧组、低剂量斑蝥素组、中剂量斑蝥素... 目的:观察斑蝥素对肺动脉平滑肌细胞增殖、自噬及PKC/ERK信号通路的作用机制。方法:2只SPF级SD大鼠处死提取肺组织中平滑肌细胞(PASMCs),采用免疫组化法检测α-SMA表达。将PASMCs细胞分为对照组、低氧组、低剂量斑蝥素组、中剂量斑蝥素组及高剂量斑蝥素组,低、中、高剂量斑蝥素组分别加入1、5、10μg/mL的斑蝥素共培养。对照组在常氧环境下培养,其余组别在低氧环境下培养。采用MTT检测各组PASMCs细胞活性;Hoechst检测凋亡率;免疫印迹检测自噬蛋白Beclin1、LC3B及PKCβⅠ、ERK1/2表达。结果:免疫组化结果显示:α-SMA在PASMCs细胞质中表达,超过90%以上的细胞呈现阳性表达,细胞形态呈现梭形,细胞内肌丝明显,证实该细胞为PASMCs细胞。与对照组比较,低氧组24 h、48 h、72 h及96 h PASMCs细胞活性均升高(P<0.05)。与低氧组比较,中、高剂量斑蝥素组48 h、72 h及96 h PASMCs细胞活性均降低(P<0.05)。与低剂量斑蝥素组比较,中、高剂量斑蝥素组24 h、48 h、72 h及96 h PASMCs细胞活性均降低,且随着剂量升高活性降低(P<0.05)。与对照组比较,低氧组PASMCs细胞凋亡率降低(P<0.05),Beclin1、LC3B、PKCβⅠ、ERK1及ERK2蛋白水平升高(P<0.05)。与低氧组比较,中、高剂量斑蝥素组PASMCs细胞凋亡率升高(P<0.05),Beclin1、LC3B、PKCβⅠ、ERK1及ERK2蛋白水平降低(P<0.05)。与低剂量斑蝥素组比较,中、高剂量斑蝥素组PASMCs细胞凋亡率升高(P<0.05),Beclin1、LC3B、PKCβⅠ、ERK1及ERK2蛋白水平降低(P<0.05)。与中剂量斑蝥素组比较,高剂量斑蝥素组PASMCs细胞凋亡率升高(P<0.05),Beclin1、LC3B、PKCβⅠ、ERK1及ERK2蛋白水平降低(P<0.05)。结论:斑蝥素可抑制细胞自噬,下调低氧状态的肺动脉平滑肌细胞增殖并加快凋亡,与降低PKC/ERK信号通路活性相关。 展开更多
关键词 肺动脉高压 肺血管平滑肌细胞 斑蝥素 自噬 蛋白激酶C 细胞外信号调节激酶
原文传递
上一页 1 2 23 下一页 到第
使用帮助 返回顶部